A. Florescu

495 total citations
9 papers, 309 citations indexed

About

A. Florescu is a scholar working on Rheumatology, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, A. Florescu has authored 9 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 3 papers in Oncology and 3 papers in Orthopedics and Sports Medicine. Recurrent topics in A. Florescu's work include Rheumatoid Arthritis Research and Therapies (6 papers), Systemic Lupus Erythematosus Research (3 papers) and Bone and Joint Diseases (2 papers). A. Florescu is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Systemic Lupus Erythematosus Research (3 papers) and Bone and Joint Diseases (2 papers). A. Florescu collaborates with scholars based in Denmark, Switzerland and United States. A. Florescu's co-authors include Jan Pødenphant, Gorm Thamsborg, Michael Stoltenberg, Eva Fallentin, Katerina Tritsaris, Peter Oturai, Steen Dissing, M. Hansen, Troels Mørk Hansen and Klaus Bendtzen and has published in prestigious journals such as Gastroenterology, Annals of the Rheumatic Diseases and Osteoarthritis and Cartilage.

In The Last Decade

A. Florescu

8 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Florescu Denmark 7 174 80 52 45 41 9 309
Manshan Xu United States 12 124 0.7× 39 0.5× 30 0.6× 163 3.6× 14 0.3× 15 461
Seung-Jun Hwang South Korea 6 119 0.7× 101 1.3× 38 0.7× 29 0.6× 78 1.9× 8 458
Brendon Richbourgh United States 6 133 0.8× 38 0.5× 15 0.3× 136 3.0× 47 1.1× 7 359
J. Clarke Stevens United States 9 53 0.3× 16 0.2× 58 1.1× 59 1.3× 61 1.5× 13 382
G. Byron Hodge United States 7 45 0.3× 99 1.2× 35 0.7× 53 1.2× 11 0.3× 9 355
G Levy United States 5 263 1.5× 18 0.2× 16 0.3× 72 1.6× 38 0.9× 8 333
Pam Kurimoto United States 7 67 0.4× 131 1.6× 9 0.2× 262 5.8× 25 0.6× 8 410
Beatriz Teresita Martín-Márquez Mexico 12 142 0.8× 20 0.3× 12 0.2× 94 2.1× 96 2.3× 33 365
Yukihiro Kohara Japan 10 79 0.5× 24 0.3× 15 0.3× 126 2.8× 18 0.4× 22 292

Countries citing papers authored by A. Florescu

Since Specialization
Citations

This map shows the geographic impact of A. Florescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Florescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Florescu more than expected).

Fields of papers citing papers by A. Florescu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Florescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Florescu. The network helps show where A. Florescu may publish in the future.

Co-authorship network of co-authors of A. Florescu

This figure shows the co-authorship network connecting the top 25 collaborators of A. Florescu. A scholar is included among the top collaborators of A. Florescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Florescu. A. Florescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Jørgensen, Anders, et al.. (2020). P.310 Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls. European Neuropsychopharmacology. 31. S53–S54. 2 indexed citations
2.
Thomas, Teresa Hagan, et al.. (2011). Post Colonoscopy Patient Education Survey; Do Patients Know Their Results and What Happens Next?. Gastroenterology. 140(5). S–18.
3.
Thamsborg, Gorm, A. Florescu, Peter Oturai, et al.. (2005). Treatment of knee osteoarthritis with pulsed electromagnetic fields: a randomized, double-blind, placebo-controlled study. Osteoarthritis and Cartilage. 13(7). 575–581. 91 indexed citations
4.
Bovin, Lone Frier, Klaus Rieneck, Christopher T. Workman, et al.. (2004). Blood cell gene expression profiling in rheumatoid arthritis. Immunology Letters. 93(2-3). 217–226. 63 indexed citations
5.
Jensen, Troels S., M. Hansen, Jesper Madsen, et al.. (2001). Serum levels of parathyroid hormone and markers of bone metabolism in patients with rheumatoid arthritis. Relationship to disease activity and glucocorticoid treatment. Scandinavian Journal of Clinical and Laboratory Investigation. 61(6). 491–501. 7 indexed citations
6.
Hansen, M., Jan Pødenphant, A. Florescu, et al.. (1999). A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side effects. Annals of the Rheumatic Diseases. 58(11). 713–718. 70 indexed citations
7.
Hansen, Michael Stormly, A. Florescu, Michael Stoltenberg, et al.. (1996). Bone Loss in Rheumatoid Arthritis: Influence of disease activity, duration of the disease, functional capacity, and corticosteroid treatment. Scandinavian Journal of Rheumatology. 25(6). 367–376. 50 indexed citations
8.
Hansen, Morten, Vibeke Andersen, A. Florescu, et al.. (1995). Cytokine Autoantibodies in Rheumatoid Arthritis. Scandinavian Journal of Rheumatology. 24(4). 197–203. 15 indexed citations
9.
Florescu, A., Jan Pødenphant, Gorm Thamsborg, et al.. (1994). Distal metacarpal bone mineral density by dual energy X-ray absorptiometry (DEXA) scan. Methodological investigation and application in rheumatoid arthritis.. PubMed. 11(6). 635–8. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026